Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

Abstract

Results of this trial demonstrated the efficacy and tolerability of adjunctive lacosamide 200 and 400 mg/day and support that lacosamide may be an advantageous option for the treatment of partial-onset seizures in patients with epilepsy.